Table 3.

Cyclodextrin-based carriers of anticancer drugs.

Serial number	Drug	Cyclodextrin	Nanocarrier prepared	Outcome	Reference
1	Doxorubicin	γ-CD	Liposomes	Increased retention in tumor cells	[59]
2	Curcumin	HP-γ-CD	Liposomes	Improvement in therapeutic efficacy	[60]
3	Methotrexate	β-CD	Niosomes	Increased entrapment efficiency and solubility	[61]
4	Camptothecin	β-CD	Nanosponges	Improvement in therapeutic efficacy and reduction in toxic effects	[62]
5	Paclitaxel	β-CD	Nanosponges	Prolonged shelf life	[63]
6	Doxorubicin	β-cyclodextrin-based star copolymers	Micelles	Enhanced drug release	[64]
7	β-lapachone	α-CD	Polymeric millirods	Sustained drug release	[65]
8	Camptothecin	Amphiphilic β-CD	Nanoparticles	Prolonged drug release	[66]
9	Paclitaxel	Amphiphilic β-CD	Nanoparticles	Increased drug loading capacity	[67]
10	Docetaxel	Amphiphilic β-CD	Nanoparticles	Increased solubility and prolonged release	[68]